;PMID: 8248934
;source_file_991.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..47] = [t:0..47]
;1)sentence:[e:53..132] = [t:53..132]
;2)section:[e:136..201] = [t:136..201]
;3)section:[e:205..294] = [t:205..294]
;4)sentence:[e:298..355] = [t:298..355]
;5)sentence:[e:356..498] = [t:356..498]
;6)sentence:[e:499..677] = [t:499..677]
;7)sentence:[e:678..781] = [t:678..781]
;8)sentence:[e:782..924] = [t:782..924]
;9)sentence:[e:926..977] = [t:926..977]
;10)sentence:[e:978..1125] = [t:978..1125]
;11)sentence:[e:1126..1258] = [t:1126..1258]
;12)sentence:[e:1259..1382] = [t:1259..1382]
;13)sentence:[e:1384..1485] = [t:1384..1485]
;14)sentence:[e:1486..1654] = [t:1486..1654]
;15)sentence:[e:1655..1783] = [t:1655..1783]
;16)sentence:[e:1784..1921] = [t:1784..1921]
;17)sentence:[e:1923..2060] = [t:1923..2060]
;18)section:[e:2064..2108] = [t:2064..2108]

;section 0 Span:0..47
;Toxicol Appl Pharmacol. 1993 Dec;123(2):274-82.
(SEC
  (FRAG (NNP:[0..7] Toxicol) (NNP:[8..12] Appl) (NNP:[13..22] Pharmacol)
        (.:[22..23] .) (CD:[24..28] 1993) (CC:[29..37] Dec;123-LRB-)
        (CD:[37..38] 2) (-RRB-:[38..39] -RRB-) (CD:[39..43] :274) (::[43..44] -)
        (CD:[44..46] 82) (.:[46..47] .)))

;sentence 1 Span:53..132
;Kinetic analysis of furan biotransformation by F-344 rats in vivo and in
;vitro.
;[73..78]:substance:"furan"
(SENT
  (NP-HLN
    (NP (JJ:[53..60] Kinetic) (NN:[61..69] analysis))
    (PP (IN:[70..72] of)
      (NP
        (NP (NN:[73..78] furan) (NN:[79..96] biotransformation))
        (PP (IN:[97..99] by)
          (NP
            (NP (NN:[100..105] F-344) (NNS:[106..110] rats))
            (ADJP
              (ADJP (FW:[111..113] in) (FW:[114..118] vivo))
              (CC:[119..122] and)
              (ADJP (FW:[123..125] in) (FW:[126..131] vitro)))))))
    (.:[131..132] .)))

;section 2 Span:136..201
;Kedderis GL, Carfagna MA, Held SD, Batra R, Murphy JE, Gargas ML.
(SEC
  (FRAG (NNP:[136..144] Kedderis) (NNP:[145..147] GL) (,:[147..148] ,)
        (NNP:[149..157] Carfagna) (NNP:[158..160] MA) (,:[160..161] ,)
        (NNP:[162..166] Held) (NNP:[167..169] SD) (,:[169..170] ,)
        (NNP:[171..176] Batra) (NNP:[177..179] R,) (NNP:[180..186] Murphy)
        (NNP:[187..189] JE) (,:[189..190] ,) (NNP:[191..197] Gargas)
        (NNP:[198..201] ML.)))

;section 3 Span:205..294
;Chemical Industry Institute of Toxicology, Research Triangle Park, North 
;Carolina 27709.
(SEC
  (FRAG (NNP:[205..213] Chemical) (NNP:[214..222] Industry)
        (NNP:[223..232] Institute) (IN:[233..235] of)
        (NNP:[236..246] Toxicology) (,:[246..247] ,) (NNP:[248..256] Research)
        (NNP:[257..265] Triangle) (NNP:[266..270] Park) (,:[270..271] ,)
        (NNP:[272..277] North) (NNP:[279..287] Carolina) (.:[288..293] 27709)
        (.:[293..294] .)))

;sentence 4 Span:298..355
;Furan is both hepatotoxic and hepatocarcinogenic in rats.
;[298..303]:substance:"Furan"
(SENT
  (S
    (NP-SBJ (NN:[298..303] Furan))
    (VP (VBZ:[304..306] is)
      (ADJP-PRD (CC:[307..311] both) (JJ:[312..323] hepatotoxic)
                (CC:[324..327] and) (JJ:[328..346] hepatocarcinogenic))
      (PP-LOC (IN:[347..349] in)
        (NP (NNS:[350..354] rats))))
    (.:[354..355] .)))

;sentence 5 Span:356..498
;The kinetics of furan  biotransformation by male F-344 rats were studied in
;vivo and in vitro in order  to understand target tissue dosimetry.
;[372..377]:substance:"furan"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[356..359] The) (NNS:[360..368] kinetics))
      (PP (IN:[369..371] of)
        (NP
          (NP (NN:[372..377] furan) (NN:[379..396] biotransformation))
          (PP (IN:[397..399] by)
            (NP (JJ:[400..404] male) (NN:[405..410] F-344) (NNS:[411..415] rats))))))
    (VP (VBD:[416..420] were)
      (VP (VBN:[421..428] studied)
        (NP-1 (-NONE-:[428..428] *))
        (ADVP
          (ADVP (FW:[429..431] in) (FW:[432..436] vivo))
          (CC:[437..440] and)
          (ADVP (FW:[441..443] in) (FW:[444..449] vitro)))
        (SBAR-PRP (IN:[450..452] in) (NN:[453..458] order)
          (S
            (NP-SBJ (-NONE-:[458..458] *))
            (VP (TO:[460..462] to)
              (VP (VB:[463..473] understand)
                (NP (NN:[474..480] target) (NN:[481..487] tissue)
                    (NN:[488..497] dosimetry))))))))
    (.:[497..498] .)))

;sentence 6 Span:499..677
;A physiologically based pharmacokinetic  (PBPK) model for furan in rats was
;developed from gas uptake studies using  initial furan concentrations of 100,
;500, 1050, and 3850 ppm.
;[557..562]:substance:"furan"
;[624..629]:substance:"furan"
;[648..651]:quantitative-value:"100"
;[653..656]:quantitative-value:"500"
;[658..662]:quantitative-value:"1050"
;[668..672]:quantitative-value:"3850"
;[673..676]:quantitative-units:"ppm"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[499..500] A)
        (ADJP
          (ADJP
            (ADJP (RB:[501..516] physiologically) (VBN:[517..522] based))
            (JJ:[523..538] pharmacokinetic))
          (ADJP (-LRB-:[540..541] -LRB-) (JJ:[541..545] PBPK)
                (-RRB-:[545..546] -RRB-)))
        (NN:[547..552] model))
      (PP (IN:[553..556] for)
        (NP
          (NP (NN:[557..562] furan))
          (PP-LOC (IN:[563..565] in)
            (NP (NNS:[566..570] rats))))))
    (VP (VBD:[571..574] was)
      (VP (VBN:[575..584] developed)
        (NP-1 (-NONE-:[584..584] *))
        (PP (IN:[585..589] from)
          (NP (NN:[590..593] gas) (NN:[594..600] uptake)
              (NNS:[601..608] studies)))
        (S-MNR
          (NP-SBJ (-NONE-:[608..608] *))
          (VP (VBG:[609..614] using)
            (NP
              (NP (JJ:[616..623] initial) (NN:[624..629] furan)
                  (NNS:[630..644] concentrations))
              (PP (IN:[645..647] of)
                (NP
                  (NP (CD:[648..651] 100)
                    (NML-2 (-NONE-:[651..651] *P*)))
                  (,:[651..652] ,)
                  (NP (CD:[653..656] 500)
                    (NML-2 (-NONE-:[656..656] *P*)))
                  (,:[656..657] ,)
                  (NP (CD:[658..662] 1050)
                    (NML-2 (-NONE-:[662..662] *P*)))
                  (,:[662..663] ,) (CC:[664..667] and)
                  (NP (CD:[668..672] 3850)
                    (NML-2 (NN:[673..676] ppm))))))))))
    (.:[676..677] .)))

;sentence 7 Span:678..781
;Tissue partition  coefficients for furan were determined in vitro using vial
;equilibration  techniques.
;[713..718]:substance:"furan"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[678..684] Tissue) (NN:[685..694] partition)
          (NNS:[696..708] coefficients))
      (PP (IN:[709..712] for)
        (NP (NN:[713..718] furan))))
    (VP (VBD:[719..723] were)
      (VP (VBN:[724..734] determined)
        (NP-1 (-NONE-:[734..734] *))
        (ADVP (FW:[735..737] in) (FW:[738..743] vitro))
        (S-MNR
          (NP-SBJ (-NONE-:[743..743] *))
          (VP (VBG:[744..749] using)
            (NP (NN:[750..754] vial) (NN:[755..768] equilibration)
                (NNS:[770..780] techniques))))))
    (.:[780..781] .)))

;sentence 8 Span:782..924
;Furan gas uptake kinetics in vivo were described by a single  saturable
;process with a Vmax of 27.0 mumol/hr/250 g rat and a KM of 2.0 microM.
;[782..787]:substance:"Furan"
;[869..873]:quantitative-name:"Vmax"
;[877..881]:quantitative-value:"27.0"
;[882..900]:quantitative-units:"mumol/hr/250 g rat"
;[907..909]:quantitative-name:"KM"
;[913..916]:quantitative-value:"2.0"
;[917..923]:quantitative-units:"microM"
(SENT
  (S
    (NP-SBJ-1
      (NP
        (NML
          (NML (NN:[782..787] Furan) (NN:[788..791] gas))
          (NN:[792..798] uptake))
        (NNS:[799..807] kinetics))
      (ADJP (FW:[808..810] in) (FW:[811..815] vivo)))
    (VP (VBD:[816..820] were)
      (VP (VBN:[821..830] described)
        (NP-1 (-NONE-:[830..830] *))
        (PP-MNR (IN:[831..833] by)
          (NP
            (NP (DT:[834..835] a) (JJ:[836..842] single)
                (JJ:[844..853] saturable) (NN:[854..861] process))
            (PP (IN:[862..866] with)
              (NP
                (NP
                  (NP (DT:[867..868] a) (NN:[869..873] Vmax))
                  (PP (IN:[874..876] of)
                    (NP
                      (NP (CD:[877..881] 27.0) (NN:[882..887] mumol))
                      (PP (SYM:[887..888] /)
                        (NP
                          (NP (NN:[888..890] hr))
                          (PP (SYM:[890..891] /)
                            (NP (CD:[891..894] 250) (NN:[895..896] g)
                                (NN:[897..900] rat))))))))
                (CC:[901..904] and)
                (NP
                  (NP (DT:[905..906] a) (NN:[907..909] KM))
                  (PP (IN:[910..912] of)
                    (NP (CD:[913..916] 2.0) (NN:[917..923] microM))))))))))
    (.:[923..924] .)))

;sentence 9 Span:926..977
;Furan metabolism in vivo was inhibited by pyrazole.
;[926..931]:substance:"Furan"
;[968..976]:substance:"pyrazole"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[926..931] Furan) (NN:[932..942] metabolism))
      (ADJP (FW:[943..945] in) (FW:[946..950] vivo)))
    (VP (VBD:[951..954] was)
      (VP (VBN:[955..964] inhibited)
        (NP-1 (-NONE-:[964..964] *))
        (PP (IN:[965..967] by)
          (NP-LGS (NN:[968..976] pyrazole)))))
    (.:[976..977] .)))

;sentence 10 Span:978..1125
;The furan PBPK model  adequately simulated blood and liver furan
;concentrations following 4-hr  inhalation exposures to 52, 107, and 208 ppm
;furan.
;[982..987]:substance:"furan"
;[1037..1042]:substance:"furan"
;[1068..1069]:quantitative-value:"4"
;[1070..1072]:quantitative-units:"hr"
;[1098..1100]:quantitative-value:"52"
;[1102..1105]:quantitative-value:"107"
;[1111..1114]:quantitative-value:"208"
;[1115..1118]:quantitative-units:"ppm"
;[1119..1124]:substance:"furan"
(SENT
  (S
    (NP-SBJ (DT:[978..981] The) (NN:[982..987] furan) (JJ:[988..992] PBPK)
            (NN:[993..998] model))
    (ADVP (RB:[1000..1010] adequately))
    (VP (VBD:[1011..1020] simulated)
      (NP
        (NP (NN:[1021..1026] blood)
          (NML-3 (-NONE-:[1026..1026] *P*)))
        (CC:[1027..1030] and)
        (NP (NN:[1031..1036] liver)
          (NML-3 (NN:[1037..1042] furan) (NNS:[1043..1057] concentrations))))
      (S-ADV
        (NP-SBJ (-NONE-:[1057..1057] *))
        (VP (VBG:[1058..1067] following)
          (NP
            (NP
              (NML (CD:[1068..1069] 4) (HYPH:[1069..1070] -)
                   (NN:[1070..1072] hr))
              (NN:[1074..1084] inhalation) (NNS:[1085..1094] exposures))
            (PP (TO:[1095..1097] to)
              (NP
                (NP
                  (NML (CD:[1098..1100] 52)
                    (NML-1 (-NONE-:[1100..1100] *P*)))
                  (NML-2 (-NONE-:[1100..1100] *P*)))
                (,:[1100..1101] ,)
                (NP
                  (NML (CD:[1102..1105] 107)
                    (NML-1 (-NONE-:[1105..1105] *P*)))
                  (NML-2 (-NONE-:[1105..1105] *P*)))
                (,:[1105..1106] ,) (CC:[1107..1110] and)
                (NP
                  (NML (CD:[1111..1114] 208)
                    (NML-1 (NN:[1115..1118] ppm)))
                  (NML-2 (NN:[1119..1124] furan)))))))))
    (.:[1124..1125] .)))

;sentence 11 Span:1126..1258
;The biotransformation of  furan was studied in freshly isolated rat
;hepatocytes in vitro and compared to  biotransformation in vivo.
;[1152..1157]:substance:"furan"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[1126..1129] The) (NN:[1130..1147] biotransformation))
      (PP (IN:[1148..1150] of)
        (NP (NN:[1152..1157] furan))))
    (VP (VBD:[1158..1161] was)
      (VP
        (VP (VBN:[1162..1169] studied)
          (NP-1 (-NONE-:[1169..1169] *))
          (PP-LOC (IN:[1170..1172] in)
            (NP
              (ADJP (RB:[1173..1180] freshly) (VBN:[1181..1189] isolated))
              (NN:[1190..1193] rat) (NNS:[1194..1205] hepatocytes)))
          (ADVP (FW:[1206..1208] in) (FW:[1209..1214] vitro)))
        (CC:[1215..1218] and)
        (VP (VBN:[1219..1227] compared)
          (NP-1 (-NONE-:[1227..1227] *))
          (PP-CLR (TO:[1228..1230] to)
            (NP
              (NP (NN:[1232..1249] biotransformation))
              (ADJP (FW:[1250..1252] in) (FW:[1253..1257] vivo)))))))
    (.:[1257..1258] .)))

;sentence 12 Span:1259..1382
;Furan biotransformation by isolated rat hepatocytes  exhibited a KM of 0.4
;microM and a Vmax of 0.018 mumol/hr/10(6) cells.
;[1259..1264]:substance:"Furan"
;[1324..1326]:quantitative-name:"KM"
;[1330..1333]:quantitative-value:"0.4"
;[1334..1340]:quantitative-units:"microM"
;[1347..1351]:quantitative-name:"Vmax"
;[1355..1360]:quantitative-value:"0.018"
;[1361..1381]:quantitative-units:"mumol/hr/10(6) cells"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1259..1264] Furan) (NN:[1265..1282] biotransformation))
      (PP (IN:[1283..1285] by)
        (NP (VBN:[1286..1294] isolated) (NN:[1295..1298] rat)
            (NNS:[1299..1310] hepatocytes))))
    (VP (VBD:[1312..1321] exhibited)
      (NP
        (NP
          (NP (DT:[1322..1323] a) (NN:[1324..1326] KM))
          (PP (IN:[1327..1329] of)
            (NP (CD:[1330..1333] 0.4) (NN:[1334..1340] microM))))
        (CC:[1341..1344] and)
        (NP
          (NP (DT:[1345..1346] a) (NN:[1347..1351] Vmax))
          (PP (IN:[1352..1354] of)
            (NP
              (NP (CD:[1355..1360] 0.018) (NN:[1361..1366] mumol))
              (PP (SYM:[1366..1367] /)
                (NP (NN:[1367..1369] hr)))
              (PP (SYM:[1369..1370] /)
                (NP (CD:[1370..1375] 10-LRB-6-RRB-) (NNS:[1376..1381] cells))))))))
    (.:[1381..1382] .)))

;sentence 13 Span:1384..1485
;Inhibition and induction studies indicated that cytochrome P450 was the
;catalyst  of furan oxidation.
;[1432..1447]:cyp450:"cytochrome P450"
;[1469..1474]:substance:"furan"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1384..1394] Inhibition)
        (NML-1 (-NONE-:[1394..1394] *P*)))
      (CC:[1395..1398] and)
      (NP (NN:[1399..1408] induction)
        (NML-1 (NNS:[1409..1416] studies))))
    (VP (VBD:[1417..1426] indicated)
      (SBAR (IN:[1427..1431] that)
        (S
          (NP-SBJ (NN:[1432..1442] cytochrome) (NN:[1443..1447] P450))
          (VP (VBD:[1448..1451] was)
            (NP-PRD
              (NP (DT:[1452..1455] the) (NN:[1456..1464] catalyst))
              (PP (IN:[1466..1468] of)
                (NP (NN:[1469..1474] furan) (NN:[1475..1484] oxidation))))))))
    (.:[1484..1485] .)))

;sentence 14 Span:1486..1654
;Acetone pretreatment of the rats produced a five-fold  increase in the rate
;of the hepatocyte oxidation of furan, suggesting an  important role for
;cytochrome P450 2E1.
;[1486..1493]:substance:"Acetone"
;[1530..1539]:quantitative-value:"five-fold"
;[1593..1598]:substance:"furan"
;[1634..1653]:cyp450:"cytochrome P450 2E1"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1486..1493] Acetone) (NN:[1494..1506] pretreatment))
      (PP (IN:[1507..1509] of)
        (NP (DT:[1510..1513] the) (NNS:[1514..1518] rats))))
    (VP (VBD:[1519..1527] produced)
      (NP
        (NP (DT:[1528..1529] a)
          (QP (CD:[1530..1534] five) (HYPH:[1534..1535] -)
              (JJ:[1535..1539] fold))
          (NN:[1541..1549] increase))
        (PP (IN:[1550..1552] in)
          (NP
            (NP (DT:[1553..1556] the) (NN:[1557..1561] rate))
            (PP (IN:[1562..1564] of)
              (NP
                (NP (DT:[1565..1568] the) (NN:[1569..1579] hepatocyte)
                    (NN:[1580..1589] oxidation))
                (PP (IN:[1590..1592] of)
                  (NP (NN:[1593..1598] furan))))))))
      (,:[1598..1599] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[1599..1599] *))
        (VP (VBG:[1600..1610] suggesting)
          (NP
            (NP (DT:[1611..1613] an) (JJ:[1615..1624] important)
                (NN:[1625..1629] role))
            (PP (IN:[1630..1633] for)
              (NP
                (NML (NN:[1634..1644] cytochrome) (NN:[1645..1649] P450))
                (NN:[1650..1653] 2E1)))))))
    (.:[1653..1654] .)))

;sentence 15 Span:1655..1783
;The Vmax determined in hepatocytes in  vitro extrapolated to 23.0
;mumol/hr/250 g rat, assuming 128 x 10(6)  hepatocytes/g liver.
;[1659..1663]:quantitative-name:"Vmax"
;[1716..1720]:quantitative-value:"23.0"
;[1721..1739]:quantitative-units:"mumol/hr/250 g rat"
;[1750..1761]:quantitative-value:"128 x 10(6)"
;[1763..1782]:quantitative-units:"hepatocytes/g liver"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1655..1658] The) (NN:[1659..1663] Vmax))
      (VP (VBN:[1664..1674] determined)
        (NP (-NONE-:[1674..1674] *))
        (PP-LOC (IN:[1675..1677] in)
          (NP (NNS:[1678..1689] hepatocytes)))
        (ADVP (FW:[1690..1692] in) (FW:[1694..1699] vitro))))
    (VP (VBD:[1700..1712] extrapolated)
      (PP (TO:[1713..1715] to)
        (NP
          (NP (CD:[1716..1720] 23.0) (NN:[1721..1726] mumol))
          (PP (SYM:[1726..1727] /)
            (NP (NN:[1727..1729] hr)))
          (PP (SYM:[1729..1730] /)
            (NP (CD:[1730..1733] 250) (NN:[1734..1735] g) (NN:[1736..1739] rat)))))
      (,:[1739..1740] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[1740..1740] *))
        (VP (VBG:[1741..1749] assuming)
          (NP
            (NP
              (QP (CD:[1750..1753] 128) (SYM:[1754..1755] x)
                  (CD:[1756..1761] 10-LRB-6-RRB-))
              (NNS:[1763..1774] hepatocytes))
            (PP (SYM:[1774..1775] /)
              (NP (NN:[1775..1776] g) (NN:[1777..1782] liver)))))))
    (.:[1782..1783] .)))

;sentence 16 Span:1784..1921
;Incorporation of the in vitro hepatocyte kinetic parameters  into the PBPK
;model for furan accurately simulated in vivo pharmacokinetics.
;[1869..1874]:substance:"furan"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1784..1797] Incorporation))
      (PP (IN:[1798..1800] of)
        (NP (DT:[1801..1804] the)
          (ADJP (FW:[1805..1807] in) (FW:[1808..1813] vitro))
          (NN:[1814..1824] hepatocyte) (JJ:[1825..1832] kinetic)
           (NNS:[1833..1843] parameters)))
      (PP (IN:[1845..1849] into)
        (NP
          (NP (DT:[1850..1853] the) (JJ:[1854..1858] PBPK)
              (NN:[1859..1864] model))
          (PP (IN:[1865..1868] for)
            (NP (NN:[1869..1874] furan))))))
    (ADVP (RB:[1875..1885] accurately))
    (VP (VBD:[1886..1895] simulated)
      (NP
        (ADJP (FW:[1896..1898] in) (FW:[1899..1903] vivo))
        (NNS:[1904..1920] pharmacokinetics)))
    (.:[1920..1921] .)))

;sentence 17 Span:1923..2060
;These results suggest that freshly isolated hepatocytes are a valuable in
;vitro  system for predicting chemical pharmacokinetics in vivo.
(SENT
  (S
    (NP-SBJ (DT:[1923..1928] These) (NNS:[1929..1936] results))
    (VP (VBP:[1937..1944] suggest)
      (SBAR (IN:[1945..1949] that)
        (S
          (NP-SBJ
            (ADJP (RB:[1950..1957] freshly) (VBN:[1958..1966] isolated))
            (NNS:[1967..1978] hepatocytes))
          (VP (VBP:[1979..1982] are)
            (NP-PRD
              (NP (DT:[1983..1984] a) (JJ:[1985..1993] valuable)
                (ADJP (FW:[1994..1996] in) (FW:[1997..2002] vitro))
                (NN:[2004..2010] system))
              (PP (IN:[2011..2014] for)
                (S-NOM
                  (NP-SBJ (-NONE-:[2014..2014] *))
                  (VP (VBG:[2015..2025] predicting)
                    (NP (JJ:[2026..2034] chemical)
                        (NNS:[2035..2051] pharmacokinetics))
                    (ADVP (FW:[2052..2054] in) (FW:[2055..2059] vivo))))))))))
    (.:[2059..2060] .)))

;section 18 Span:2064..2108
;PMID: 8248934 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[2064..2068] PMID) (::[2068..2069] :) (CD:[2070..2077] 8248934)
        (NN:[2078..2079] -LSB-) (NNP:[2079..2085] PubMed) (::[2086..2087] -)
        (NN:[2088..2095] indexed) (IN:[2096..2099] for)
        (NNP:[2100..2108] MEDLINE-RSB-)))
